Literature DB >> 17287732

Commercial interest grows in glycan analysis.

Cormac Sheridan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17287732     DOI： 10.1038/nbt0207-145

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies.

Authors:  Hongwei Xie; Asish Chakraborty; Joomi Ahn; Ying Qing Yu; Deepalakshmi P Dakshinamoorthy; Martin Gilar; Weibin Chen; St John Skilton; Jeffery R Mazzeo
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

2.  Modifications of therapeutic proteins: challenges and prospects.

Authors:  Nigel Jenkins
Journal:  Cytotechnology       Date:  2007-05-25       Impact factor: 2.058

3.  European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UK.

Authors:  Janice M Reichert; Alain Beck; Harish Iyer
Journal:  MAbs       Date:  2009-09-25       Impact factor: 5.857

Review 4.  Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications.

Authors:  Anshu Kuriakose; Narendra Chirmule; Pradip Nair
Journal:  J Immunol Res       Date:  2016-06-29       Impact factor: 4.818

5.  A library of chemically defined human N-glycans synthesized from microbial oligosaccharide precursors.

Authors:  Brian S Hamilton; Joshua D Wilson; Marina A Shumakovich; Adam C Fisher; James C Brooks; Alyssa Pontes; Radnaa Naran; Christian Heiss; Chao Gao; Robert Kardish; Jamie Heimburg-Molinaro; Parastoo Azadi; Richard D Cummings; Judith H Merritt; Matthew P DeLisa
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.